Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
Platelet blood cells can carry an enzyme needed to prevent clots, while hiding it from autoantibody neutralization.
Pretreatment with the NSAID carprofen before experimental heart attack in mice caused a diminished resolution of acute inflammation.
This knowledge can aid vaccine development, treatment of infections and moderation of autoimmune disease.
Examination of a larger group of patients extends the clinical manifestations first described 11 years ago.
This research suggests a therapeutic approach to treating human heart failure.
This novel mechanism links epigenetic changes to translational control.
Sensitive, specific assays are needed to ensure the safety of inter-species transplants for patients needing new organs like kidneys and hearts.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
This remarkable ability has clinical implications for humans.
The symposium puts a spotlight on interdisciplinary research at the University of Alabama at Birmingham.